Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression- Clinical and Mechanistic Impact.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 09 May 2017 Status changed from completed to discontinued.
- 26 Oct 2016 Status changed from recruiting to completed.
- 29 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.